Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") ...
Hollyland, a leading provider of professional wireless intercom solutions, unveiled its latest innovation, the Cosmo C2. This ...
According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...
Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...
News Medical on MSN18h
Oral vancomycin induces PSC-IBD remission, driving gut microbiome and metabolic shiftsIn a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of additional years of healthy life globally. Some examples of disease areas in which ...
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of ...
China continued to strike economic deals with African countries, particularly in infrastructure, sustainable development, and ...
DelveInsight's Artificial Kidney Market Insights report provides the current and forecast market analysis, individual leading ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
Features Analysis of Major Players Appasamy Associates Private Limited, Carl Zeiss Meditec AG, DGH Technology Inc., Halma plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback